About Eric Gornstein
Eric Gornstein is CEO and director at Pearl Diagnostics.
Experience
This experience comes from Eric Gornstein's profile and from SEC filings. For roles taken from filings, the years are when the filings name Eric Gornstein in the role, so the role may have started earlier or lasted longer.
Pearl Diagnostics, Inc. Current
Chief Executive Officer (2025 – Present)
Director
2025 – Present · Baltimore, MD
Urine tests help clinicians diagnose lung infections.
CA
CapyBio Current
Advisor
2025 – Present
BB
bit.bio
Senior Vice President BD & Cell Therapy Partnerships
2023 – 2025
TT
Talaris Therapeutics
Senior Vice President, Strategy
2019 – 2023
RI
Radius Health, Inc.
Senior Director, Insights and Analytics
2015 – 2019
NC
Navigant (formerly Leerink Swann Consulting)
Director, Life Sciences Consulting
2013 – 2015
AS
AstraZeneca
External Insights Director, New Opportunities iMed Strategy
2011 – 2013
AP
Acceleron Pharma
Director, Market and Business Development
2009 – 2011
AR
Archemix
Director, Commercial Evaluation
2006 – 2009
TJ
Transform Pharmaceuticals (acquired by J&J)
Manager, New Products
2004 – 2006
MP
Millennium Pharmaceuticals
Manager, Market Research
2002 – 2004
BI
Biogen
Associate, New Product Commercialization
2000 – 2002
Key Colleagues at Startups
The people Eric Gornstein works with at each company, as listed on that company's latest Form D.
Pearl Diagnostics, Inc. · Form D, Apr 21, 2026
